Subscribe

Risk Factors for Sensorineural Deafness Following Therapy with a Phosphodiesterase (PDE) Inhibitor

Specialty:

Neurology, Psychiatry, Ophthalmology & Otolaryngology
Neurology, Psychiatry, Ophthalmology & Otolaryngology

Objective:

ICD-10:

Description:

Despite its mention in drug advertisements, sensorineural hearing loss associated with phosphodiesterase (PDE) inhibitors is extremely rare. Some experimental studies in animals indicate that it can occur under certain circumstances. Ototoxicity may be encountered more frequently as the role of PDE inhibitors expands.

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone